Jeffrey P. Ward

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text

MHC-II neoantigens shape tumour immunity and response to immunotherapy

Elise Alspach, Danielle M. Lussier, Alexander P. Miceli et al. · Nature · 2019 · 837 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Mhc-ii Neoantigens +6

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

Stephen T. Ferris, Vivek Durai, Renee Wu et al. · Nature · 2020 · 537 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, T-regulatory Cell +14

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang et al. · Cell · 2020 · 507 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Medicine +12

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward et al. · Cell · 2018 · 407 citations · Full text

Tumor Biology, Lymphoid Neoplasia, Medicine +9